Global Lumakras Drug Market is estimated to register a CAGR of XX% over the forecast period (2022 – 2030).. The Major players profiled in this report include: Amgen Inc., Boehringer Ingelheim, Eli Lilly and Company, Mirati Therapeutics Inc., Moderna Inc., Oblique Therapeutics AB, Revolution Medicines Inc., Silenseed LTD, Other Market Participants.
Download Sample (FREE) @ https://www.absolutemarketsinsights.com/request_sample.php?id=1089&rp
It Becomes easy to achieve supreme level of market insights and obtain knowhow of the best market opportunities into the specific markets with an outstanding Lumakras Drug Market report. The report lists down the company profiles of major market players and brands which explore their actions about product launches, product enhancements, joint ventures, mergers and acquisitions with respect to effect on the sales, import, export, revenue and CAGR values.
The finest market report puts light on various factors that have direct or indirect effect on the growth of business which includes historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in this industry. This market research report identifies as well as analyses the emerging trends along with major driving factors, challenges and opportunities in the market for industry.
Purchase the latest in-depth Single-Use Sterile Devices Market report: https://www.absolutemarketsinsights.com/checkout?id=1089&rp
Lumakras is a drug that is used to treat adults with non-small cell lung cancer (NSCLC) that has spread and has a mutation (change) in the KRAS gene. It’s given to patients who have already had at least one other systemic treatment. According to the American Cancer Society, most lung cancer data include both small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). SCLC accounts for about 13% of all lung cancers, while NSCLC accounts for 84%. Furthermore, the American Society of Clinical Oncology projected that 2.3 million people would be diagnosed with lung cancer worldwide in 2021. In the United States, an estimated 235,760 adults (119,100 men and 116,660 women) were diagnosed with the disease in the same year. Lung cancer is one of the most common cancer and the leading cause of cancer death. This disease is expected to cause deaths of 131,880 people (69,410 men and 62,470 women) in the United States in 2021.
Increasing pipeline medicines related to the lumakras drug is one of the significant factors expected to drive the growth of lumakras drug market over the forecast period. Rising incidence of various cancers, as well as growing popularity of advanced therapies, are fuelling the market growth. Major players are also contributing to market growth through developments. For instance, Mirati Therapeutics, Inc., a clinical-stage targeted oncology corporation, announced positive topline results from the potentially registration-allowing cohort of Phase 2 KRYSTAL-1 study, evaluating adagrasib in patients with advanced non-small-cell lung cancer (NSCLC) harboring the KRASG12C mutation consistent with previous systemic therapy, in September 2021. The company intends to publish detailed data from the KRYSTAL-1 study’s continuing Phase 2 registration-enabling cohort in previously treated patients with KRASG12C-mutated NSCLC at a medical congress in early 2022.
SARS-CoV-2 (COVID-19) is one of the most serious public health emergencies the civilization has ever seen, with more than 770,000 deaths and immeasurable economic costs. COVID-19 was declared a global pandemic by the World Health Organization on March 12, 2020, as the epidemic condition worsened. In the first half of 2020, the impact of the COVID-19 pandemic on cancer care has led to decreases and delays in detecting new cancers and providing treatment. However, now that the covid-19 illnesses is being handled effectively by economies, key players and the government are focusing more proactively on other diseases, including cancer. The enhanced promise of innovation in cancer therapy showcases potential opportunities for lumakras drug market participants in the healthcare industry to develop in the near future.
Global Lumakras Drug Market:
- By Therapy Type
- Combination Therapy
- By Disease Indication
- Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
- Metastatic Non-Small Cell Lung Cancer (NSCLC)
- By Region
- North America
- Rest of North America
- The UK
- Nordic Countries
- Benelux Union
- The Netherlands
- Rest of Europe
- Asia Pacific
- New Zealand
- South Korea
- Southeast Asia
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- Latin America
- Rest of Latin America
- North America
To identify the key trends in the industry, research study : https://www.absolutemarketsinsights.com/reports/Global-Lumakras-Drug-Market-2021-2029-1089
Absolute Markets Insights is an International Market Research and Intelligence firm. We help companies find the market data and industry analysis they need to make informed decisions. Our research scope and methodologies provides information on products, trends, regions, demographics, industries and companies.
We are the leading market research service provider for international market. Our project managers, consultants, analysts and researchers work 24×6 to address your market research requirements. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
We are a one-stop-shop for market research studies across the globe.
With market research you can get some kind of confirmation that there is a market for your idea, and that a successful launch and growth are possible.
Examples of Market Information Questions:
- Who are the customers?
- Where are they located and how can they be contacted?
- What quantity and quality do they want?
- What is the best time to sell?
- What is the long-term or historical price data over a number of years?
- What is the expected production in the country?
- Is there more demand for one product or another?
Browse more trending reports by Absolute Markets Insights:
Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email Id: [email protected]
Phone: IN +91-7400-24-24-24, US +1-510-420-1213